chr10-49610781-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_003055.3(SLC18A3):c.41C>A(p.Ala14Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000541 in 1,570,492 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A14V) has been classified as Benign.
Frequency
Consequence
NM_003055.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC18A3 | NM_003055.3 | c.41C>A | p.Ala14Asp | missense_variant | 1/1 | ENST00000374115.5 | |
CHAT | NM_020984.4 | c.-69+1582C>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC18A3 | ENST00000374115.5 | c.41C>A | p.Ala14Asp | missense_variant | 1/1 | NM_003055.3 | P1 | ||
CHAT | ENST00000339797.5 | c.-69+1582C>A | intron_variant | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 181570Hom.: 0 AF XY: 0.0000406 AC XY: 4AN XY: 98580
GnomAD4 exome AF: 0.0000585 AC: 83AN: 1418238Hom.: 1 Cov.: 79 AF XY: 0.0000684 AC XY: 48AN XY: 702258
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152254Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74378
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 13, 2023 | The c.41C>A (p.A14D) alteration is located in exon 1 (coding exon 1) of the SLC18A3 gene. This alteration results from a C to A substitution at nucleotide position 41, causing the alanine (A) at amino acid position 14 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | May 16, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces alanine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 14 of the SLC18A3 protein (p.Ala14Asp). This variant is present in population databases (rs199520651, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with SLC18A3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at